1615.6000 16.40 (1.03%)
NSE Jun 10, 2025 15:31 PM
Volume: 736.1K
 

1615.60
1.03%
KRChoksey
Glenmark Pharma’s revenue was largely in-line with our estimates due to strong growth in India and Europe. However, EBITDA missed our estimates due to higher-than-expected employee expenses and other expenses.
Glenmark Pharmaceuticals Ltd. has gained 15.55% in the last 1 Month
More from Glenmark Pharmaceuticals Ltd.
Recommended